Pages that link to "Q44444385"
Jump to navigation
Jump to search
The following pages link to Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis (Q44444385):
Displaying 35 items.
- Quantitative real time polymerase chain reaction for measurement of human interleukin-5 receptor alpha spliced isoforms mRNA (Q24792565) (← links)
- Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options (Q26771860) (← links)
- Anti-IL5 therapy for asthma and beyond (Q26866943) (← links)
- Adhesion molecules and their ligands in nasal polyps of aspirin-hypersensitive patients (Q28194664) (← links)
- Association of stem cell factor expression in nasal polyp epithelial cells with aspirin sensitivity and asthma (Q28212158) (← links)
- Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis (Q28217896) (← links)
- Pathophysiology of nasal congestion (Q30481517) (← links)
- A review of nasal polyposis (Q30493657) (← links)
- Structural organization and cellular localization of tuftelin-interacting protein 11 (TFIP11). (Q34415626) (← links)
- IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis (Q35490676) (← links)
- Defective eosinophil hematopoiesis ex vivo in inbred Rocky Mountain White (IRW) mice (Q35609388) (← links)
- Rhinosinusitis: Establishing definitions for clinical research and patient care (Q35971352) (← links)
- Pharmacological management of nasal polyposis (Q36201583) (← links)
- A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory disease (Q36809701) (← links)
- Nasal inflammation induced by a common cold: comparison between controls and patients with nasal polyposis under topical steroid therapy. (Q37092059) (← links)
- Significance of susceptible gene expression profiles in nasal polyposis (Q37165556) (← links)
- Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue (Q37173474) (← links)
- Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management. (Q37832984) (← links)
- Molecular and clinical rationale for therapeutic targeting of interleukin‐5 and its receptor (Q37957225) (← links)
- Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma (Q38074647) (← links)
- Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis (Q38736622) (← links)
- A Multi-omics Approach to Identify Genes Associated with Childhood Asthma Risk and Morbidity. (Q38748762) (← links)
- Soluble interleukin-5 receptor alpha is increased in acute exacerbation of chronic obstructive pulmonary disease (Q47948358) (← links)
- Assessment of the effectiveness of cyclosporine nasal spray in an animal model of allergic rhinitis. (Q48126820) (← links)
- Local immunoglobulin production in nasal polyposis is modulated by superantigens. (Q49041126) (← links)
- Differentiation of chronic sinus diseases by measurement of inflammatory mediators (Q49072771) (← links)
- Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps. (Q49147180) (← links)
- Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis. (Q54342829) (← links)
- Effect of mitomycin C in eosinophilic nasal polyposis, in vivo: concentration of IL5 and GM-CSF, RT-PCR. (Q54586888) (← links)
- Interleukin-5 does not influence differential transcription of transmembrane and soluble isoforms of IL-5R alpha in vivo. (Q54591393) (← links)
- Rhinosinusitis: establishing definitions for clinical research and patient care (Q81092861) (← links)
- A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease (Q87947907) (← links)
- IL-5Rα marks nasal polyp IgG4 and IgE-expressing cells in aspirin-exacerbated respiratory disease (Q90566786) (← links)
- Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art (Q92890397) (← links)
- The use of biologics in children with allergic rhinitis and chronic rhinosinusitis: Current updates (Q98772414) (← links)